Preclinical evaluation of Tc direct labeling Z for HER2 positive tumors imaging

about

Preclinical evaluation of Tc direct labeling Z for HER2 positive tumors imaging

Item

http://www.wikidata.org/entity/Q58794885

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Preclinical evaluation of Tc direct labeling Z for HER2 positive tumors imaging

@en

Preclinical evaluation of Tc direct labeling Z for HER2 positive tumors imaging

@nl

type

Item

label

Preclinical evaluation of Tc direct labeling Z for HER2 positive tumors imaging

@en

Preclinical evaluation of Tc direct labeling Z for HER2 positive tumors imaging

@nl

prefLabel

Preclinical evaluation of Tc direct labeling Z for HER2 positive tumors imaging

@en

Preclinical evaluation of Tc direct labeling Z for HER2 positive tumors imaging

@nl

P1476

Preclinical evaluation of Tc direct labeling Z for HER2 positive tumors imaging

@en

P2093

Jianfang Wang

http://www.w3.org/2001/XMLSchema#string

Jingmian Zhang

http://www.w3.org/2001/XMLSchema#string

Tianying Yu

http://www.w3.org/2001/XMLSchema#string

Xinming Zhao

http://www.w3.org/2001/XMLSchema#string

Yang Yang

http://www.w3.org/2001/XMLSchema#string

Yu Xing

http://www.w3.org/2001/XMLSchema#string

P2860

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Update: affibody molecules for molecular imaging and therapy for cancer.

(99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors.

Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.

Strategies to target HER2/neu overexpression for cancer therapy.

H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy

Evaluation of 99mTc-peptide-ZHER2:342 Affibody® molecule for in vivo molecular imaging.

Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications.

Influence of labelling methods on biodistribution and imaging properties of radiolabelled peptides for visualisation of molecular therapeutic targets.

A gradient-loadable (64)Cu-chelator for quantifying tumor deposition kinetics of nanoliposomal therapeutics by positron emission tomography.

P304

5361-5366

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.9279

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30250607

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6144291

http://www.w3.org/2001/XMLSchema#string